Genomic
Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.0001 per share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 21st Floor
New
York, NY 10065
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
|
||||
August
12, 2010
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 37244C101
|
Page
2 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian C. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
o
(b)
o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o | |||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
41,250
|
|||
8
|
SHARED
VOTING POWER
6,510,937
|
||||
9
|
SOLE
DISPOSITIVE POWER
41,250
|
||||
10
|
SHARED
DISPOSITIVE POWER
6,510,937
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,552,187
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o | |||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.7%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 37244C101
|
Page
3 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) o
(b)
o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o | |||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
6,510,937
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
6,510,937
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,510,937
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o | |||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.6%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Item
5.
|
Interest
in Securities of the Issuer.
|
Name
|
Number
of Shares
|
Percent
of Class
Outstanding
|
||||||
Baker
Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker
Bros. Investments II, L.P.
|
20,287 | 0.1 | % | |||||
667,
L.P.
|
1,253,653 | 4.4 | % | |||||
Baker
Brothers Life Sciences, L.P.
|
4,570,896 | 15.8 | % | |||||
14159,
L.P.
|
124,146 | 0.4 | % | |||||
FBB
Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch
Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian
C. Baker
|
41,250 | 0.1 | % | |||||
Total
|
6,552,187 | 22.7 | % |
Name
|
Date
|
Number
of
|
||||||||
Shares
|
Transaction
|
Price
/ Share
|
||||||||
Baker
Brothers Life Sciences, L.P.
|
8/6/2010
|
10,556 |
Purchase
|
14.1823 | ||||||
14159,
L.P.
|
8/6/2010
|
291 |
Purchase
|
14.1823 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/6/2010
|
34,371 |
Purchase
|
14.1556 | ||||||
14159,
L.P.
|
8/6/2010
|
949 |
Purchase
|
14.1556 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/9/2010
|
46,260 |
Purchase
|
14.8042 | ||||||
14159,
L.P.
|
8/9/2010
|
1,277 |
Purchase
|
14.8042 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/9/2010
|
16,350 |
Purchase
|
14.8197 | ||||||
14159,
L.P.
|
8/9/2010
|
451 |
Purchase
|
14.8197 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/10/2010
|
37,242 |
Purchase
|
14.7896 | ||||||
14159,
L.P.
|
8/10/2010
|
1,028 |
Purchase
|
14.7896 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/10/2010
|
19,463 |
Purchase
|
14.6649 | ||||||
14159,
L.P.
|
8/10/2010
|
537 |
Purchase
|
14.6649 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/11/2010
|
18,893 |
Purchase
|
14.7418 | ||||||
14159,
L.P.
|
8/11/2010
|
522 |
Purchase
|
14.7418 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/11/2010
|
9,313 |
Purchase
|
14.7051 | ||||||
14159,
L.P.
|
8/11/2010
|
257 |
Purchase
|
14.7051 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/12/2010
|
12,294 |
Purchase
|
15.0119 | ||||||
14159,
L.P.
|
8/12/2010
|
339 |
Purchase
|
15.0119 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/12/2010
|
9,425 |
Purchase
|
14.9976 | ||||||
14159,
L.P.
|
8/12/2010
|
260 |
Purchase
|
14.9976 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/12/2010
|
8,577 |
Purchase
|
14.9389 | ||||||
14159,
L.P.
|
8/12/2010
|
237 |
Purchase
|
14.9389 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/13/2010
|
38,494 |
Purchase
|
14.8475 | ||||||
14159,
L.P.
|
8/13/2010
|
1,063 |
Purchase
|
14.8475 | ||||||
Baker
Brothers Life Sciences, L.P.
|
8/13/2010
|
8,914 |
Purchase
|
14.8070 | ||||||
14159,
L.P.
|
8/13/2010
|
246 |
Purchase
|
14.8070 |
Item
6.
|
Contracts,
Arrangements, Understandings or Relationships with Respect to Securities
of the Issuer.
|
Item
7.
|
Material
to Be Filed as Exhibits.
|
Exhibit
1.
|
Agreement
regarding the joint filing of this
statement.
|